Authors:
Clark, WF
Churchill, DN
Forwell, L
Macdonald, G
Foster, S
Citation: Wf. Clark et al., To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy, CAN MED A J, 162(2), 2000, pp. 195-198
Authors:
Skaper, SD
Kee, WJ
Facci, L
Macdonald, G
Doherty, P
Walsh, FS
Citation: Sd. Skaper et al., The FGFR1 inhibitor PD 173074 selectively and potently antagonizes FGF-2 neurotrophic and neurotropic effects, J NEUROCHEM, 75(4), 2000, pp. 1520-1527
Citation: M. Morrison et al., Identifying conduct problems in young children - Developmental pathways and risk factors, INT SOC W, 43(4), 2000, pp. 467
Authors:
Genski, T
Macdonald, G
Wei, XD
Lewis, N
Taylor, RJK
Citation: T. Genski et al., Epoxidation of electron deficient alkenes using tert-butyl hydroperoxide and 1,5,7-triazabicyclo[4.4.0]dec-5-ene and its derivatives, SYNLETT, (6), 1999, pp. 795-797
Authors:
Alcaraz, L
Macdonald, G
Ragot, J
Lewis, NJ
Taylor, RJK
Citation: L. Alcaraz et al., Synthetic approaches to the manumycin A, B and C antibiotics: The first total synthesis of (+)-manumycin A, TETRAHEDRON, 55(12), 1999, pp. 3707-3716
Authors:
Ellem, KAO
Schmidt, CW
Li, CL
Misko, I
Kelso, A
Sing, G
Macdonald, G
O'Rourke, MGE
Citation: Kao. Ellem et al., The labyrinthine ways of cancer immunotherapy - T cell, tumor cell encounter: "How do I lose thee? Let me count the ways", ADV CANC R, 75, 1998, pp. 203-249